ArticleFrontiers in pharmacology2022

The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth By Enhancing the DNA Damaging Effect and Modulating the Akt/mTOR and MAPK Signaling Pathways.

Hao-Cheng Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.